This site is intended for healthcare professionals
News

TGA approves use of Trikafta to treat cystic fibrosis F508del mutation in Australia. - Vertex

Read time: 1 mins
Last updated:25th Mar 2021
Published:26th Mar 2021
Condition: Cystic Fibrosis-F508del-gene
Type: drug
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest